Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Co‐operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor

Co‐operative signalling mechanisms required for erythroid precursor expansion in response to... The regeneration of circulating red blood cells in response to anaemia associated with blood loss or haemolysis involves an increased rate of erythropoiesis and expansion of proerythroblasts, the bone marrow precursor cells that terminally differentiate into mature erythrocytes. This study investigated the mechanisms by which erythropoietin (Epo) and stem cell factor (Scf) modulate the expansion of proerythroblasts. Homogenous populations of primary human proerythroblasts were generated in liquid cultures of CD34+ cells. In serum‐free cultures, proerythroblasts failed to survive in the presence of Epo or Scf alone, but exhibited synergistic proliferation in response to combined Epo and Scf treatment, exhibiting one‐log expansion in 5 d. Intracellular signal transduction in response to Epo and Scf revealed that tyrosine phosphorylation of signal transducers and activators of transcription (Stat) 5, a downstream target for the non‐receptor tyrosine kinase, Janus kinase 2 (Jak2), was mediated by Epo but not Scf. The mitogen‐activated protein kinases (MAPKs) extracellular regulated kinase (Erk) 1–2 were phosphorylated in response to either Epo or Scf. Phosphorylation of Akt, a signalling molecule downstream of phosphatidylinositol 3‐kinase (PI3K), was observed following Scf but not Epo treatment. To determine the contribution of specific signalling pathways to synergistic expansion of proerythroblasts in response to co‐operative effects of Epo and Scf, cells were treated with kinase inhibitors targeting Jak2, PI3K and MAPK kinase. There was a significant, dose‐dependent inhibition of proerythroblast expansion in response to all three kinase inhibitors. In conclusion, Epo‐ and Scf‐mediated co‐operative, synergistic expansion of primary erythroid precursors requires selective activation of multiple signalling pathways, including the Jak‐Stat, PI3K and MAPK pathways. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png British Journal of Haematology Wiley

Co‐operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor

Download PDF
9 pages

Loading next page...
 
/lp/wiley/co-operative-signalling-mechanisms-required-for-erythroid-precursor-vD84MBBpdK

References (43)

Publisher
Wiley
Copyright
Copyright © 2005 Wiley Subscription Services
ISSN
0007-1048
eISSN
1365-2141
DOI
10.1111/j.1365-2141.2005.05580.x
pmid
15982354
Publisher site
See Article on Publisher Site

Abstract

The regeneration of circulating red blood cells in response to anaemia associated with blood loss or haemolysis involves an increased rate of erythropoiesis and expansion of proerythroblasts, the bone marrow precursor cells that terminally differentiate into mature erythrocytes. This study investigated the mechanisms by which erythropoietin (Epo) and stem cell factor (Scf) modulate the expansion of proerythroblasts. Homogenous populations of primary human proerythroblasts were generated in liquid cultures of CD34+ cells. In serum‐free cultures, proerythroblasts failed to survive in the presence of Epo or Scf alone, but exhibited synergistic proliferation in response to combined Epo and Scf treatment, exhibiting one‐log expansion in 5 d. Intracellular signal transduction in response to Epo and Scf revealed that tyrosine phosphorylation of signal transducers and activators of transcription (Stat) 5, a downstream target for the non‐receptor tyrosine kinase, Janus kinase 2 (Jak2), was mediated by Epo but not Scf. The mitogen‐activated protein kinases (MAPKs) extracellular regulated kinase (Erk) 1–2 were phosphorylated in response to either Epo or Scf. Phosphorylation of Akt, a signalling molecule downstream of phosphatidylinositol 3‐kinase (PI3K), was observed following Scf but not Epo treatment. To determine the contribution of specific signalling pathways to synergistic expansion of proerythroblasts in response to co‐operative effects of Epo and Scf, cells were treated with kinase inhibitors targeting Jak2, PI3K and MAPK kinase. There was a significant, dose‐dependent inhibition of proerythroblast expansion in response to all three kinase inhibitors. In conclusion, Epo‐ and Scf‐mediated co‐operative, synergistic expansion of primary erythroid precursors requires selective activation of multiple signalling pathways, including the Jak‐Stat, PI3K and MAPK pathways.

Journal

British Journal of Haematology – Wiley

Published: Jan 1, 2005

Keywords: ; ; ; ;

There are no references for this article.